The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 ...

A patient at The Meadows Psychiatric Center was arrested Wednesday for an assault that state police at Rockview said sent at ...

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.

Prime Therapeutics reviewed pharmacy and medical claims data for 3,046 people with commercial health plans that cover GLP-1 ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...